[1] KRISHNAMURTHI R V,FEIGIN V L,FOROUZANFAR M H,et al.Global and re-gional burden of first-everischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet Glob Health,2013,1( 5) : 259-281.
[2] BANERJEE C,CHIMOWITZ M I.Stroke caused by atherosclerosis of the majorin tracranial arteries[J]. J Vascul Surg,2017,120(3):502-513.
[3] 王维治,罗祖明,崔丽英,等.神经病学[M]. 北京:人民卫生出版社,2017.
[4] 马学盛.清化血浊法治疗缺血性脑损伤的作用及机制研究[D]. 山东中医药大学,2007.
[5] 宗寿健,胡晓洁,王兴臣.化浊和血颗粒治疗缺血性脑血管病临床疗效总结[J]. 天津中医药,2014,4(31):199-202.
[6] 中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[7] ADAMS HP J R,BENDIXEN B H,KAPPELLE L J,et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke,1993,24(1):35-41.
[8] 国家中医药管理局脑病急症科研协作组.中风病辨证诊断标准(试行)[J]. 北京中医药大学学报,1991,17(3):64.
[9] BROTT T,ADAMS H P,OLINGER C P,et al. Measurements of acute cerebral Infarction:a clinical examination scale[J]. Stroke,1989(20):864.
[10] 刘秋皖,吴竹青,王小强,等.大动脉粥样硬化型脑卒中患者应用大剂量瑞舒伐他汀的临床观察[J].中华老年心脑血管病杂志,2018,20(3):278-281.
[11] 王新陆,王栋先.血浊的性质特点和辨证论治[J].天津中医药,2020,37(2):148-152.
[12] 刘艺,侯佳欣,张风霞.从血浊角度浅议缺血性脑卒中的防治[J].世界最新医学信息文摘,2019,19(6),226-228.
[13] 宗寿健,王兴臣,蔡敏,等.化浊行血汤治疗短暂性脑缺血临床研究[J].山东中医杂志,2012,31(7):483-484. |
